| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,812,000 | 3,713,000 | 3,308,000 | 3,751,000 | | Cost of Revenue | 545,000 | 531,000 | 477,000 | 558,000 | | | Gross Profit | 3,267,000 | 3,182,000 | 2,831,000 | 3,193,000 | | | Operating Expenses | | Research Development | 647,000 | 693,000 | 633,000 | 798,000 | | Selling General and Administrative | 995,000 | 910,000 | 798,000 | 1,491,000 | | Non Recurring | (54,000) | 49,000 | 5,000 | (306,000) | | Others | 74,000 | 73,000 | 74,000 | 73,000 | | | | Total Operating Expenses | 1,662,000 | 1,725,000 | 1,510,000 | 2,056,000 | | | | Operating Income or Loss | 1,605,000 | 1,457,000 | 1,321,000 | 1,137,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 74,000 | 197,000 | (89,000) | 333,000 | | Earnings Before Interest And Taxes | 1,679,000 | 1,654,000 | 1,232,000 | 1,470,000 | | Interest Expense | 139,000 | 297,000 |
-
| 316,000 | | Income Before Tax | 1,540,000 | 1,357,000 | 1,232,000 | 1,154,000 | | Income Tax Expense | 154,000 | 88,000 | 213,000 | 193,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,386,000 | 1,269,000 | 1,019,000 | 961,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,386,000 | 1,269,000 | 1,019,000 | 961,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,386,000 | $1,269,000 | $1,019,000 | $961,000 |
|
1.48% Nasdaq 
Income Statement
